TP53 and neoplasm: If our TP53-loss phenocopy indeed predicts chemo-sensitivity as our in-vitro and clinical data suggest, we would expect that chemotherapy would cause a reduction in phenocopy tumor cells as the most sensitive cells are killed, matching our observation in this dataset.